RELX PLC (RLXXF) Statistics & Valuation Metrics - Stock Analysis

The stock price has increased by +41.67% in the last 52 weeks. The beta is 0.48, so RELX PLC's price volatility has been lower than the market average. Beta (5Y)

67%
OFF

RELX PLC (RLXXF) Statistics & Valuation Metrics - Stock Analysis

2 weeks from now

The stock price has increased by +41.67% in the last 52 weeks. The beta is 0.48, so RELX PLC's price volatility has been lower than the market average. Beta (5Y)

stockanalysis.com

09%
OFF

RLXXF Key Stats | RELX - YCharts

2 weeks from now

RLXXF key financial statistics including returns, dividends, risk metrics, margins and valuation ratios. RELX PLC (RLXXF) 42.54-2.28 (-5.09% ... presented with a look and feel of a …

ycharts.com

2%
OFF

Relx (RLXXF) Stock Price, News & Analysis - MarketBeat

2 weeks from now

4 days ago · Relx's stock was trading at $43.89 on January 1st, 2025. Since then, RLXXF stock has increased by 6.2% and is now trading at $46.60. View the best growth stocks for 2025 here .

marketbeat.com

FAQs about RELX PLC (RLXXF) Statistics & Valuation Metrics - Stock Analysis Coupon?

Should you buy RELX plc (RELX)?

The prestigious CODiE Awards recognize the companies producing the most innovative Business Technology products across the country and around the world. RELX PLC (RELX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. ...

What is the revenue of RELX?

RELX's revenue for the year was $0M, a NAN% increase year-over-year. ...

Is RELX a FTSE 100 company?

RELX is a FTSE 100 diversified information and analytics company. The firm operates across four main areas: scientific, technical, and medical (34% of 2019 sales); risk and business analytics (29%); legal (21%); and exhibitions (16%). RELX Group has three listings: its primary one in London and two more in New York and Amsterdam. ...

What does rlxxf stand for?

RELX plc (RLXXF) Company Description: RELX is a FTSE 100 diversified information and analytics company. The firm operates across four main areas: scientific, technical, and medical (34% of 2019 sales); risk and business analytics (29%); legal (21%); and exhibitions (16%). ...